Business
Trinity Biotech Appoints Paul Tivnan as Non-Executive Director
DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Paul Tivnan to its Board of Directors as a Non-Executive Director. Mr. Tivnan brings over 25 years of senior leadership experience in finance, capital markets, and corporate governance across the infrastructure, energy, shipping, and cleantech sectors
About this update from Ardmore Shipping Corporation
[{"type":"image","alt":"Trinity Biotech plc","displaySize":"","headline":null,"caption":"Trinity Biotech plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":190,"height":40,"url":"https://media.zenfs.com/en/globenewswire.com/e0e43b72a3dd3c748ba888c67eaab82c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/s3SctPWnHdsIfurC_.Vv0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/e0e43b72a3dd3c748ba888c67eaab82c","width":190,"height":40}},"lazy":false},{"type":"text","content":"DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Paul Tivnan to its Board of Directors as a Non-Executive Director.","length":315,"tagName":"p"},{"type":"text","content":"Mr. Tivnan brings over 25 years of senior leadership experience in finance, capital markets, and corporate governance across the infrastructure, energy, shipping, and cleantech sectors. He currently serves as Chief Financial Officer of Deriva Energy LLC, one of the largest independent renewable power producers in the United States and a Brookfield portfolio company. His previous roles include CFO of Brookfield Renewable Ireland and CFO of Ardmore Shipping Corporation, where he led the company’s successful IPO on the New York Stock Exchange in 2013. Mr. Tivnan has also served as a Director of Element 1 Corp, a developer of advanced hydrogen technologies.","length":661,"tagName":"p"},{"type":"text","content":"John Gillard, President and Chief Executive Officer of Trinity Biotech, commented: “We are delighted to welcome Paul to the Board. His extensive experience in capital markets and operational leadership across large scale global sectors will be invaluable to our company as we continue to execute our transformation strategy and pursue growth opportunities in diagnostics and wearable health technologies. Paul’s appointment reflects our commitment to strengthening our corporate governance and bringing diverse, high-impact and international perspectives to the Board, as Trinity Biotech continues to transform and develop.”","length":624,"tagName":"p"},{"type":"text","content":"Mr. Tivnan is a Certified International Director from INSEAD Business Scho...